Hurricane Sandy Exacerbates Propofol Shortage

APP Pharmaceuticals is facing delays on inbound shipments and product releases of proposal, exacerbating the shortage situation and creating some back-orders for ASCs, according to an ASCA report.

Advertisement

APP has told the FDA they are committed to resolving the distribution challenges as quickly as possible. The FDA is working with all propofol manufacturers to ensure propofol can reach the market as soon as possible.

Learn more about ASCA.

Related Articles on Anesthesia:
AcelRx to Seek Approval for Pain Controlling Drug Device
Marine Corps Looks for Small Rugged Anesthesia Machines
Equity Firm Industry Experts Team Up to Form US Anesthesia Partners

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.